Retour sur lavenir.net
   ACKERMANS V.HAAREN 271.800 € (-0,59 %)     AGEAS 75.200 € (-0,40 %)     ARGENX SE 886.200 € (+1,21 %)     SHURGARD 23.000 € (+0,66 %)     KBC ANCORA 93.200 € (0,00 %)     GIMV 43.500 € (-0,80 %)     KBC 130.050 € (-0,73 %)     AB INBEV 68.460 € (+0,26 %)     D'IETEREN GROUP 177.200 € (-0,84 %)     CENERGY 22.440 € (-2,09 %)     RECTICEL 13.040 € (-0,76 %)     MELEXIS 64.400 € (-2,42 %)     KINEPOLIS GROUP 47.550 € (+1,82 %)     CMB.TECH 15.660 € (-0,25 %)     INCLUSIO SA/NV 16.900 € (-0,29 %)     SOLVAY 25.760 € (-0,31 %)     VASTNED 28.500 € (-1,38 %)     ENERGYVISION 15.100 € (-0,40 %)     CARE PROPERTY INV. 12.000 € (0,00 %)     RETAIL ESTATES 65.000 € (-0,46 %)     COLRUYT 39.360 € (+1,44 %)     HOME INVEST BE. 19.080 € (-0,42 %)     VAN DE VELDE 30.500 € (+0,66 %)     BPOST 1.292 € (0,00 %)     UMICORE 23.000 € (-2,79 %)     BQUE NAT. BELGIQUE 382.000 € (+0,53 %)     ELIA GROUP 126.300 € (-1,56 %)     TUBIZE-FIN 185.000 € (+0,49 %)     WERELDHAVE BELGIUM 51.200 € (-0,39 %)     ONTEX GROUP 2.625 € (-2,96 %)     LOTUS BAKERIES 12 840.000 € (+0,63 %)     MONTEA 64.500 € (0,00 %)     ECONOCOM GROUP 1.470 € (-2,00 %)     SOFINA 242.600 € (-1,70 %)     TESSENDERLO 22.650 € (-1,31 %)     ASCENCIO 51.900 € (+0,58 %)     JENSEN-GROUP 74.000 € (-1,07 %)     DECEUNINCK 2.440 € (+0,41 %)     IBA 15.900 € (-0,87 %)     CIE BOIS SAUVAGE 295.000 € (-0,34 %)     SYENSQO 79.250 € (-2,40 %)     SIPEF 105.200 € (+0,19 %)     IMMOBEL 21.000 € (+2,44 %)     DEME GROUP 179.000 € (+2,52 %)     BARCO 7.845 € (+0,13 %)     AEDIFICA 68.100 € (+0,29 %)     EVS 29.300 € (-0,85 %)     MATERIALISE 6.200 € (-0,80 %)     FLUXYS BELGIUM D 22.300 € (-3,04 %)     TINC 11.100 € (-0,36 %)     WDP 21.380 € (+1,81 %)     NYXOAH 1.338 € (-3,88 %)     AGFA-GEVAERT 0.470 € (-0,42 %)     EKOPAK 3.905 € (-9,08 %)     ONWARD MEDICAL 2.440 € (-1,61 %)     BEKAERT 38.300 € (-1,92 %)     BIOTALYS 2.440 € (-1,61 %)     FAGRON 22.300 € (+0,22 %)     BREDERODE 103.600 € (-0,38 %)     PROXIMUS 6.265 € (-1,34 %)  
   AEGON 7.994 € (+0,63 %)     EMEIS 13.190 € (+0,84 %)     MEDINCELL 24.040 € (-0,83 %)     ENGIE 24.400 € (-0,81 %)     WOLTERS KLUWER 69.780 € (-0,09 %)     ORANGE 15.510 € (+0,68 %)     ASML HOLDING 1 435.400 € (-1,13 %)     HERMES INTL 1 542.500 € (-2,44 %)     COGRA 7.180 € (+3,46 %)     AIRBUS 196.180 € (-0,54 %)     CSG 17.354 € (-4,28 %)     SOCIETE GENERALE 73.290 € (+0,88 %)     SOITEC 110.550 € (-3,79 %)     THALES 238.600 € (-2,09 %)     AALBERTS NV 42.880 € (-2,19 %)     EXOSENS 57.150 € (-1,55 %)     MAUNA KEA TECH 0.155 € (0,00 %)     STMICROELECTRONICS 42.305 € (-1,65 %)     ID LOGISTICS GROUP 332.500 € (+0,15 %)     TIKEHAU CAPITAL 16.520 € (-1,31 %)     VALNEVA 2.806 € (+3,62 %)     ATON 0.016 € (-2,44 %)     HAL TRUST 160.600 € (-0,50 %)     BOLLORE 3.868 € (+0,73 %)     MYHOTELMATCH 0.179 € (-0,56 %)     PRODWAYS GROUP 0.586 € (-5,18 %)     S.E.B. 60.550 € (+1,09 %)     THEON INTERNAT 32.840 € (-1,02 %)     CVC CAPITAL 14.000 € (-3,25 %)     VOLTALIA 6.600 € (-3,37 %)     GTT 210.800 € (+0,48 %)     LOUIS HACHETTE 1.787 € (-0,17 %)     CREDIT AGRICOLE 18.580 € (+0,35 %)     ALSTOM 15.830 € (-3,24 %)     AHOLD DEL 30.840 € (+0,62 %)     2CRSI 25.720 € (-2,58 %)     CAPGEMINI 106.600 € (-0,61 %)     ATOS GROUP 27.760 € (-0,79 %)     BOUYGUES 44.380 € (+0,36 %)     AIR LIQUIDE 173.180 € (+2,15 %)     ACOMO 24.200 € (+0,21 %)     UMG 14.350 € (-2,05 %)     SANOFI 76.860 € (+0,07 %)     ALTAREA 92.000 € (-2,02 %)     CAPITAL B 0.503 € (-5,17 %)     PERNOD RICARD 62.540 € (-3,04 %)     SHELL PLC 40.155 € (+2,08 %)     VINCI 114.100 € (+0,84 %)     SCHNEIDER ELECTRIC 288.200 € (-2,17 %)     AXA 43.710 € (+1,42 %)     TOTALENERGIES 77.610 € (+2,75 %)     PUBLICIS GROUPE SA 99.400 € (-1,54 %)     DANONE 64.540 € (+0,40 %)     KPN KON 4.091 € (-0,99 %)     SCOR SE 34.300 € (+1,54 %)     BUREAU VERITAS 27.190 € (-0,33 %)     KERING 247.200 € (-2,70 %)     ADP 106.100 € (-1,76 %)     DSM FIRMENICH AG 95.500 € (-0,25 %)     X-FAB 5.860 € (-3,14 %)  
News Réglementées
01/09/2026 07:38

Symrise signs agreement to divest its Terpene Ingredients business to Mutares SE & Co. KGaA

EQS-News: Symrise AG / Key word(s): Disposal
Symrise signs agreement to divest its Terpene Ingredients business to Mutares SE & Co. KGaA

01.09.2026 / 07:38 CET/CEST
The issuer is solely responsible for the content of this announcement.


Press Release

Holzminden, Germany, September 1, 2026

Symrise signs agreement to divest its Terpene Ingredients business to Mutares SE & Co. KGaA
  • Positions AmeriTerpenes LLC for long-term growth under Mutares' ownership
  • Advances the ONE Symrise strategy through continued portfolio management
  • Secures long-term supply, customer service, and commercial partnership between Symrise and AmeriTerpenes

Symrise AG has signed a definitive agreement to sell AmeriTerpenes LLC, its terpene ingredients business, to international private equity investor Mutares SE & Co. KGaA. With this divestment, Symrise sharpens its portfolio and concentrates management attention on core growth platforms under the ONE Symrise strategy. The agreement supports customer continuity and positions AmeriTerpenes to further develop its renewable terpene ingredient portfolio for fragrance, flavor, and industrial applications under focused ownership.

AmeriTerpenes, a leading producer of renewable terpene ingredients, is serving customers across fragrance, flavor and industrial applications from its US-based manufacturing sites in Jacksonville, Florida and Colonels Island, Georgia. Terpene ingredients play a key role in fragrance, flavor, and industrial formulations, where customers seek renewable, consistent, and high-performing ingredient solutions. With the successful operational carve-out completed over the past months, the business has positioned itself well to continue its development under new ownership.

The divestiture enables Symrise to further sharpen its portfolio and increase management focus on its core growth platforms, while supporting the company's long-term ambition to deliver sustainable profitable growth, operational excellence, and disciplined capital allocation under the ONE Symrise strategy.

Dr Jean-Yves Parisot, CEO of Symrise AG, commented: "This transaction gives a good example of how we are actively shaping Symrise for the future with continued portfolio management: AmeriTerpenes is a strong business with excellent people, longstanding customer relationships and differentiated manufacturing capabilities. We are pleased that, with Mutares, we have found an experienced owner that brings a strong operational track record in corporate carve-outs and is well-suited to support AmeriTerpenes into its future. We also look forward to continuing our partnership with AmeriTerpenes and Mutares as its new owner through strategic agreements entered into as part of the transaction."

The acquisition of AmeriTerpenes represents a new platform investment for Mutares' Chemicals & Materials segment and further strengthens the Group's footprint in the strategically important U.S. market.

Johannes Laumann, CIO of Mutares, commented: "With this transaction, we are adding a strong platform to our Chemicals & Materials segment while further strengthening our presence in the U.S. market. As a corporate carve-out, the company offers exactly the type of special situation, for which we have designed our investment approach. This deal marks the promise to deliver our strategy of strong growth in the segment and the U.S. market."

Symrise and Mutares are committed to ensuring a seamless transition, maintaining business continuity, customer service excellence and strong relationships with customers and suppliers. Following closing, Symrise and AmeriTerpenes will continue their long-standing commercial relationship. The agreed supply arrangements secure long-term access to renewable, terpene-based raw materials and create an enduring industrial partnership that supports both companies’ future growth plans.

The signing and closing of the transaction took place simultaneously. Both parties to the transaction have agreed to keep financial details relating to the transaction confidential.

The transaction is expected to result in a non-cash disposal loss amounting to a mid-double-digit million-euro impact, which will reflect in Symrise's annual financial statements 2026.

Symrise was advised by Stifel (Financial Adviser), Alvarez & Marsal (Carve-Out and Vendor Due Diligence Adviser) and Troutman Pepper Locke (Legal Adviser).

About Mutares

Mutares SE & Co. KGaA, Munich (www.mutares.com), is a listed private equity holding company with offices in Munich (HQ), Amsterdam, Bad Wiessee, Chicago, Frankfurt, Helsinki, London, Madrid, Milan, Mumbai, Paris, Shanghai, Stockholm, Tokyo, Warsaw, and Vienna, which acquires companies in transition that show significant potential for operational improvement and are resold after stabilization and repositioning. The company follows a sustainable minimum dividend policy.

The shares of Mutares SE & Co. KGaA are traded on the Regulated Market of the Frankfurt Stock Exchange under the symbol “MUX” (ISIN: DE000A2NB650) and are included in the SDAX selection index.

About Symrise

Symrise is a global supplier of flavors and fragrances, cosmetic base and active ingredients, and functional ingredients. Its customers include manufacturers of perfume, cosmetics, food and beverages, as well as the pharmaceutical industry and producers of dietary supplements and pet food.

With sales of around €4.9 billion in the 2025 financial year, the company is one of the world’s leading providers. Headquartered in Holzminden, Germany, the Group has more than 100 sites in Europe, Africa and the Middle East, Asia, North America, and Latin America.

Together with its customers, Symrise develops new ideas and market-ready concepts for products that have become an indispensable part of everyday life. Economic success and corporate responsibility are inextricably linked. Symrise – always inspiring more...             

www.symrise.com

Media contact:

Christina Witter
Phone: +49 55 31 90-2182
E-mail: christina.witter@symrise.com

Social media:

linkedin.com/company/Symrise youtube.com/agsymrise
xing.com/companies/symrise instagram.com/symriseag
instagram.com/finefragrancestories_bySymrise instagram.com/symrise.ci



01.09.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language:English
Company:Symrise AG
Mühlenfeldstraße 1
37603 Holzminden
Germany
Phone:+49 (0)5531 90 0
E-mail:ir@symrise.com
Internet:www.symrise.com
ISIN:DE000SYM9999, DE000SYM7787, DE000SYM7704
WKN:SYM999
Indices:DAX
Listed:Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX
LEI Code:529900D82I6R9601CF26
EQS News ID:2391384

 
End of NewsEQS News Service

2391384  01.09.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière